1. Home
  2. ILAG vs OGEN Comparison

ILAG vs OGEN Comparison

Compare ILAG & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILAG
  • OGEN
  • Stock Information
  • Founded
  • ILAG N/A
  • OGEN 1996
  • Country
  • ILAG Hong Kong
  • OGEN United States
  • Employees
  • ILAG N/A
  • OGEN N/A
  • Industry
  • ILAG Office Equipment/Supplies/Services
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ILAG Consumer Discretionary
  • OGEN Health Care
  • Exchange
  • ILAG Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • ILAG 14.0M
  • OGEN 9.8M
  • IPO Year
  • ILAG 2022
  • OGEN N/A
  • Fundamental
  • Price
  • ILAG $0.83
  • OGEN $1.04
  • Analyst Decision
  • ILAG
  • OGEN
  • Analyst Count
  • ILAG 0
  • OGEN 0
  • Target Price
  • ILAG N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • ILAG 233.1K
  • OGEN 155.2K
  • Earning Date
  • ILAG 08-06-2024
  • OGEN 08-12-2024
  • Dividend Yield
  • ILAG N/A
  • OGEN N/A
  • EPS Growth
  • ILAG N/A
  • OGEN N/A
  • EPS
  • ILAG N/A
  • OGEN N/A
  • Revenue
  • ILAG $6,443,357.00
  • OGEN $20,629.00
  • Revenue This Year
  • ILAG N/A
  • OGEN N/A
  • Revenue Next Year
  • ILAG N/A
  • OGEN N/A
  • P/E Ratio
  • ILAG N/A
  • OGEN N/A
  • Revenue Growth
  • ILAG N/A
  • OGEN N/A
  • 52 Week Low
  • ILAG $0.33
  • OGEN $0.97
  • 52 Week High
  • ILAG $1.19
  • OGEN $7.74
  • Technical
  • Relative Strength Index (RSI)
  • ILAG 70.69
  • OGEN 37.79
  • Support Level
  • ILAG $0.63
  • OGEN $1.00
  • Resistance Level
  • ILAG $1.02
  • OGEN $1.09
  • Average True Range (ATR)
  • ILAG 0.13
  • OGEN 0.07
  • MACD
  • ILAG 0.03
  • OGEN 0.02
  • Stochastic Oscillator
  • ILAG 70.53
  • OGEN 17.50

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: